Evidence map›Paper›PMID 33013861›Full record

ArticleFrontiers in immunology2020

Clinical-Pathological Features and Outcome of Atypical Anti-glomerular Basement Membrane Disease in a Large Single Cohort.

Cong-Rong Shen, Xiao-Yu Jia, Zhao Cui, Xiao-Juan Yu, Ming-Hui Zhao

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Atypical Anti-Glomerular Basement Membrane Disease.Kidney international reports · 2026
    Article
  4. Article
  5. Perlecan is a novel target of autoantibodies in anti-glomerular basement membrane disease.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2025
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Atypical Anti-Glomerular Basement Membrane Disease.Kidney international reports · 2023
    Review
  15. Article
  16. Review
  17. Article
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Cong-Rong ShenRenal Division, Peking University First Hospital, Beijing, China.
Xiao-Yu JiaRenal Division, Peking University First Hospital, Beijing, China.
Zhao CuiRenal Division, Peking University First Hospital, Beijing, China.
Xiao-Juan YuRenal Division, Peking University First Hospital, Beijing, China.
Ming-Hui ZhaoRenal Division, Peking University First Hospital, Beijing, China.
Ministry of Education of the People's Republic of China · CNPeking University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedAnti-Glomerular Basement Membrane DiseaseAutoantibodiesBiomarkersBiopsyCohort StudiesComplement C3Disease ManagementDisease ProgressionDisease SusceptibilityFemaleFluorescent Antibody TechniqueGlomerular Basement MembraneHumansMaleantiglomerular basement membrane antibodyAutoantibodiesBiomarkersComplement C3anti-GBM diseasecrescentic glomerulonephritisrapidly progressive glomerulonephritisrenal outcomerenal pathology

Identifiers

PMID33013861
PMCPMC7494752
OpenAlexW3083666150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.